People · Operator
Named in public records as an officer, director or promoter · active 2011–2020 · Biotechnology, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Apollo Endosurgery Us Inc | — | Biotechnology | Series C | $175.9M | $2.2B | 2016 |
| Navitor Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $68.2M | $686.4M | 2020 |
| Bi02 Medical, Inc. | — | Biotechnology | Series A | $35.6M | $54.2M | 2012 |
| Bioptix Diagnostics, Inc. | — | Other | Series A | $28.0M | $37.3M | 2013 |
| Peloton Therapeutics, Inc. | — | Biotechnology | Series A | $13.7M | $423.0M | 2011 |
John Creecy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Creecy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Brown | 1 | 34 |
| Jean-Francois Formela | 1 | 17 |
| Kevin Bitterman | 1 | 15 |
| Jack Nielsen | 1 | 13 |
| Brian Gallagher | 1 | 11 |
| David Goeddel | 1 | 10 |
| Kyle Lefkoff | 1 | 9 |
| Alan Crane | 1 | 9 |
| Rajeev Dadoo | 1 | 7 |
| Bruce Robertson | 1 | 7 |
| Tim Kutzkey | 1 | 7 |
| Jack B. Nielsen | 1 | 6 |
| William Marshall | 1 | 6 |
| Paul Castella | 1 | 6 |
| William Coleman | 1 | 5 |
| Paul Friedman | 1 | 5 |
| THOMAS HUGHES | 1 | 4 |
| Dmitry Akhanov | 1 | 4 |
| J. William Freytag | 1 | 4 |
| Rick Anderson | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.